← Leaderboards
John M Kaldor
Natl Centre/Hiv Epidemiology/Clncl Res
$2,065,537
Attributed
$2,065,537
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $558.5K · FY2005–07$1M$750K$500K$250K$0
'05
'06
'07
Funding mix
By agency
NIH$2,065,537 · 2
By mechanism
R01$1,892,507 · 1
R34$173,030 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Disease /Disorder Onset”
- John C S Breitner · Johns Hopkins University$34,318,149
- Jane S Paulsen · University Of Wisconsin-Madison$11,722,243
- Sarah E. Fowler · George Washington University$11,378,408
- Mary Sano · Columbia University Health Sciences$11,194,655
- Kathleen Anne Welsh-Bohmer · Duke University$8,898,383
- Richard Mayeux · Columbia University Health Sciences$8,885,610
Research focus
Disease /Disorder OnsetDisease /Disorder Proneness /RiskDrug Screening /EvaluationRelapse /RecurrenceEnzyme Linked Immunosorbent AssayData Collection Methodology /EvaluationHuman Therapy EvaluationImmunotherapyInterferonsIntravenous Drug AbuseLiver Disorder DiagnosisLongitudinal Human StudyMental Disorder DiagnosisPolymerase Chain ReactionPrognosisQuestionnairesTherapy ComplianceAntiviral AgentsVirus LoadClinical ResearchHepatitis CHepatitis C VirusHuman Population StudyHuman Subject
Grant awards (6)
Longitudinal cohort of newly acquired HCV infection$379,345
R01 · FY2007 · DA · contact PI
Longitudinal cohort of newly acquired HCV infection$385,435
R01 · FY2006 · DA · contact PI
Safety/pharmacokinetics of tenofovir & emtricitabine in HIV negative Thai women$173,030
R34 · FY2006 · AI · contact PI
Longitudinal cohort of newly acquired HCV infection$389,499
R01 · FY2005 · DA
Longitudinal cohort of newly acquired HCV infection$384,435
R01 · FY2004 · DA
Longitudinal cohort of newly acquired HCV infection$353,793
R01 · FY2003 · DA